130 related articles for article (PubMed ID: 37926973)
1. Method for determination of elemental impurities in metronidazole benzoate using inductively coupled plasma mass spectrometry.
Tian M; Zhang H; Fan H; Yin M; Wang W; Shi C
Eur J Mass Spectrom (Chichester); 2024 Feb; 30(1):60-64. PubMed ID: 37926973
[TBL] [Abstract][Full Text] [Related]
2. Determination of arsenic, cadmium, mercury, lead and nickel as elemental impurities in atorvastatin calcium by inductively coupled mass spectrometer.
Pal AK; Sundararajan R
Eur J Mass Spectrom (Chichester); 2022 Feb; 28(1-2):3-11. PubMed ID: 35656753
[TBL] [Abstract][Full Text] [Related]
3. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B
PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213
[TBL] [Abstract][Full Text] [Related]
4. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
[TBL] [Abstract][Full Text] [Related]
5. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D.
Pluháček T; Ručka M; Maier V
Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206
[TBL] [Abstract][Full Text] [Related]
6. Elemental impurities determination in bromhexine hydrochloride injections.
Xu S; Zhang L; Bai Q; Wang L; Chen X
J Pharm Biomed Anal; 2023 May; 229():115379. PubMed ID: 37011549
[TBL] [Abstract][Full Text] [Related]
7. Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.
Fischer L; Zipfel B; Koellensperger G; Kovac J; Bilz S; Kunkel A; Venzago C; Hann S
J Pharm Biomed Anal; 2014 Jul; 95():121-9. PubMed ID: 24667566
[TBL] [Abstract][Full Text] [Related]
8. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS.
Janchevska K; Stafilov T; Memed-Sejfulah S; Bogdanoska M; Ugarkovic S; Petrushevski G
Drug Dev Ind Pharm; 2020 Mar; 46(3):456-461. PubMed ID: 31999195
[TBL] [Abstract][Full Text] [Related]
9. Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug products.
Menoutis J; Parisi A; Verma N
J Pharm Biomed Anal; 2018 Apr; 152():12-16. PubMed ID: 29414002
[TBL] [Abstract][Full Text] [Related]
10. Study and determination of elemental impurities by ICP-MS in active pharmaceutical ingredients using single reaction chamber digestion in compliance with USP requirements.
Muller AL; Oliveira JS; Mello PA; Muller EI; Flores EM
Talanta; 2015 May; 136():161-9. PubMed ID: 25702998
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Extractable Elements from Elastomers.
Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
[TBL] [Abstract][Full Text] [Related]
12. Elemental Impurities in Pharmaceutical Excipients.
Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
[TBL] [Abstract][Full Text] [Related]
13. Greening microwave-assisted digestion method using hydrogen peroxide for determination of elemental impurities by ICP-OES in antihypertensive active pharmaceutical ingredients.
Senger CM; Dornelles IS; Queiroz JM; Mello PA; Muller EI; Muller ALH
J Pharm Biomed Anal; 2024 Jan; 238():115802. PubMed ID: 37871418
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉.
Chahrour O; Malone J; Collins M; Salmon V; Greenan C; Bombardier A; Ma Z; Dunwoody N
J Pharm Biomed Anal; 2017 Oct; 145():84-90. PubMed ID: 28654780
[TBL] [Abstract][Full Text] [Related]
15. Quality of Active Pharmaceutical Ingredients Present on Algerian Soil: Control of Impurities of Ciprofloxacin, Metronidazole and Fluconazole.
Matmour D; Achachi N; Toumi H
Ann Pharm Fr; 2022 May; 80(3):261-272. PubMed ID: 34687670
[TBL] [Abstract][Full Text] [Related]
16. Clean Chemistry for Elemental Impurities Analysis of Pharmaceuticals in Compliance with USP 232.
Jin C
AAPS PharmSciTech; 2016 Oct; 17(5):1141-9. PubMed ID: 26586536
[TBL] [Abstract][Full Text] [Related]
17. Rapid screening of pharmaceutical products for elemental impurities by a high-resolution portable energy dispersive X-ray fluorescence spectrometer using an efficient fundamental parameter method.
Zhu L; Teng Y; Han W; Yin L; Teng X
Analyst; 2023 Feb; 148(5):1116-1122. PubMed ID: 36723086
[TBL] [Abstract][Full Text] [Related]
18. A Risk-Based Approach to Evaluate and Control Elemental Impurities in Therapeutic Proteins.
Luo Y; Sekhar C; Lee H; Fujimori K; Ronk M; Semin D; Nashed-Samuel Y
J Pharm Sci; 2020 Nov; 109(11):3378-3385. PubMed ID: 32745562
[TBL] [Abstract][Full Text] [Related]
19. Determination of elemental impurities in pharmaceutical products and related matrices by ICP-based methods: a review.
Barin JS; Mello PA; Mesko MF; Duarte FA; Flores EM
Anal Bioanal Chem; 2016 Jul; 408(17):4547-66. PubMed ID: 27020927
[TBL] [Abstract][Full Text] [Related]
20. [The modern approaches to the determination of the content of elemental impurities in the pharmaceutical substances with the use of inductively-coupled plasma mass-spectrometry].
Bol'shov MA; Seregina IF; Uspenskaya EV; Titorovich OV; Syroeshkin AV; Maksimova TV; Pletneva TV
Sud Med Ekspert; 2015; 58(6):31-33. PubMed ID: 26856057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
